JP2009508916A5 - - Google Patents

Download PDF

Info

Publication number
JP2009508916A5
JP2009508916A5 JP2008531764A JP2008531764A JP2009508916A5 JP 2009508916 A5 JP2009508916 A5 JP 2009508916A5 JP 2008531764 A JP2008531764 A JP 2008531764A JP 2008531764 A JP2008531764 A JP 2008531764A JP 2009508916 A5 JP2009508916 A5 JP 2009508916A5
Authority
JP
Japan
Prior art keywords
composition according
solidified melt
paracetamol
melt particles
solidified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008531764A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009508916A (ja
Filing date
Publication date
Priority claimed from GBGB0519350.3A external-priority patent/GB0519350D0/en
Application filed filed Critical
Publication of JP2009508916A publication Critical patent/JP2009508916A/ja
Publication of JP2009508916A5 publication Critical patent/JP2009508916A5/ja
Pending legal-status Critical Current

Links

JP2008531764A 2005-09-22 2006-09-07 Nsaidとパラセタモールを含んだ組成物 Pending JP2009508916A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0519350.3A GB0519350D0 (en) 2005-09-22 2005-09-22 Therapeutic agents
PCT/GB2006/003297 WO2007034135A1 (en) 2005-09-22 2006-09-07 Composition comprising a nsaid and paracetamol

Publications (2)

Publication Number Publication Date
JP2009508916A JP2009508916A (ja) 2009-03-05
JP2009508916A5 true JP2009508916A5 (enExample) 2009-10-22

Family

ID=35335274

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008531764A Pending JP2009508916A (ja) 2005-09-22 2006-09-07 Nsaidとパラセタモールを含んだ組成物

Country Status (13)

Country Link
US (1) US20090142392A1 (enExample)
EP (2) EP2851068B1 (enExample)
JP (1) JP2009508916A (enExample)
KR (2) KR20130141728A (enExample)
CN (1) CN101267807B (enExample)
AU (1) AU2006293798B2 (enExample)
CA (1) CA2623281A1 (enExample)
GB (1) GB0519350D0 (enExample)
PL (2) PL1926477T3 (enExample)
RU (1) RU2438656C2 (enExample)
SG (1) SG149080A1 (enExample)
WO (1) WO2007034135A1 (enExample)
ZA (1) ZA200802436B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5630943B2 (ja) 2004-07-07 2014-11-26 エイ・エフ・ティ・ファーマスーティカルズ・リミテッドAft Pharmaceuticals Limited 複合剤組成物
GB2447898B (en) * 2007-03-24 2011-08-17 Reckitt Benckiser Healthcare A tablet having improved stability with at least two actives
CA2712010A1 (en) * 2008-01-11 2009-07-12 Cipla Limited Solid pharmaceutical dosage form
JPWO2009128543A1 (ja) * 2008-04-17 2011-08-04 ニプロ株式会社 シリカを含む錠剤の製造方法、錠剤及び錠剤用複合粒子
KR20110112279A (ko) * 2008-10-14 2011-10-12 에이에프티 파마슈티칼스 리미티드 의약품 및 치료
ES2365961B1 (es) * 2010-03-30 2013-01-24 Farmasierra Manufacturing S.L. Formulación farmacéutica a base de ibuprofeno y codeína de estabilidad mejorada.
CN105816434B (zh) * 2016-04-19 2019-09-17 山东新华制药股份有限公司 布洛芬颗粒及其制备方法
EP3700509B1 (en) 2017-11-29 2023-11-22 Ilko Ilaç Sanayi Ve Ticaret Anonim Sirketi Color stable fixed dose tablet combination of ibuprofen and paracetamol
US20190350883A1 (en) * 2018-05-20 2019-11-21 Luan Chau Pharmaceutical Composition of Acetaminophen/Ibuprofen
US11197830B2 (en) 2019-02-27 2021-12-14 Aft Pharmaceuticals Limited Pharmaceutical composition containing acetaminophen and ibuprofen
US11779541B2 (en) 2019-03-26 2023-10-10 Johnson & Johnson Consumer Inc. Immediate release dosage form
KR20220027194A (ko) 2019-06-27 2022-03-07 글락소스미스클라인 컨슈머 헬스케어 홀딩스 (유에스) 엘엘씨 신규 이부프로펜 및 아세트아미노펜 조성물
CN110372713B (zh) * 2019-08-15 2022-05-17 广州市汉普医药有限公司 一种普拉洛芬的精制纯化方法
WO2023281089A2 (en) 2021-07-08 2023-01-12 Krka, D.D., Novo Mesto Pharmaceutical composition comprising naproxen and paracetamol

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5271811A (en) * 1988-01-29 1993-12-21 Hoechst Celanese Corporation Process for purifying 2-(4-isobutylphenyl)-propionic acid by vacuum distillation
DE3802619C1 (enExample) 1988-01-29 1989-09-07 Hoechst Ag, 6230 Frankfurt, De
DE3833448A1 (de) 1988-10-01 1990-04-12 Hoechst Ag Verfahren zur gewinnung von ibuprofen fuer die direkttablettierung
JP3122748B2 (ja) * 1991-11-29 2001-01-09 ライオン株式会社 イブプロフェン含有解熱鎮痛剤
US5409709A (en) * 1991-11-29 1995-04-25 Lion Corporation Antipyretic analgesic preparation containing ibuprofen
DE4418837A1 (de) 1994-05-30 1995-12-07 Bayer Ag Thermisches Granulierverfahren
DE4446468A1 (de) * 1994-12-23 1996-06-27 Basf Ag Verfahren zur Herstellung von umhüllten Tabletten
JP3982889B2 (ja) * 1997-11-28 2007-09-26 あすか製薬株式会社 イブプロフェン含有医薬製剤
US6787157B1 (en) * 1998-03-10 2004-09-07 Abbott Laboratories Multiphase active ingredient-containing formulations
RU2192248C2 (ru) * 1998-07-13 2002-11-10 Товарищество с ограниченной ответственностью фирма "Эйкос" Препарат "антигриппин"
DE60027761T2 (de) * 1999-12-09 2007-01-25 Reckitt Benckiser Healthcare (Uk) Ltd., Slough Komprimierte zubereitung enthaltend nichtsteroidale entzündungshemmer
GB0113841D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
RU2237470C1 (ru) * 2003-01-27 2004-10-10 Купсин Евгений Вениаминович Комбинированный препарат для устранения симптомов простудных заболеваний и гриппа (варианты)
US20040265378A1 (en) * 2003-06-25 2004-12-30 Yingxu Peng Method and compositions for producing granules containing high concentrations of biologically active substances
EP1804772B1 (en) * 2004-08-12 2011-10-05 Reckitt Benckiser Healthcare (UK) Limited Granules comprising a non-steroidal anti-inflammatory drug and a sugar alcohol made by melt extrusion
GB0423103D0 (en) * 2004-10-19 2004-11-17 Boots Healthcare Int Ltd Therapeutic agents

Similar Documents

Publication Publication Date Title
JP2015515459A5 (enExample)
JP2003516341A5 (enExample)
JP2009536147A5 (enExample)
HRP20170624T1 (hr) Derivat piridina i pirazina za liječenje kronične opstrukcijske plućne bolesti
JP2005515966A5 (enExample)
JP2009500443A5 (enExample)
RU2007126652A (ru) Композиции и способы стабилизации активных фармацевтических ингредиентов
WO2007012019A3 (en) Medicaments containing famotidine and ibuprofen and administration of same
JP2006527256A5 (enExample)
JP2009517411A5 (enExample)
JP2013541583A5 (enExample)
EA200901146A1 (ru) Твердые лекарственные формы, содержащие алискирен и его фармацевтически приемлемые соли
HRP20161470T1 (hr) Smjese flurbiprofena s kontroliranim otpuštanjem i mišićnog relaksanta
JP2011506587A5 (enExample)
JP2005533751A5 (enExample)
RU2008115507A (ru) Композиция, включающая нпвс и парацетамол
CA2797551A1 (en) Melt-granulated fingolimod
JP2014012660A (ja) ロキソプロフェン含有医薬組成物
CN103120688A (zh) 一种闪释制剂的药物组合
JP2006503095A5 (enExample)
CN101856338A (zh) 枸橼酸钾缓释丸剂
JP2008534523A5 (enExample)
JP2004522780A5 (enExample)
JP2008505935A5 (enExample)
JP2017511350A5 (enExample)